Related content

Combined PET/CT in the follow-up of differentiated thyroid carcinoma: what is the impact of each modality?

By Zoller Michael   Kohlfuerst Susanne   Igerc Isabel   Kresnik Ewald   Gallowitsch Hans-Jürgen   Gomez Iris   Lind Peter  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 34, Iss. 4, 2007-04 ,pp. : 487-495

Springer Publishing Company

Access to resources Recommend Favorite

Diagnostic accuracy of ²⁰¹Thallium-SPECT and ¹⁸F-FDG-PET in the clinical assessment of glioma recurrence

By Gómez-Río Manuel   Rodríguez-Fernández Antonio   Ramos-Font Carlos   López-Ramírez Escarlata   Llamas-Elvira José  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 35, Iss. 5, 2008-05 ,pp. : 966-975

Springer Publishing Company

Access to resources Recommend Favorite

Clinical Impact of 18F-FDG-PET in the Suspicion of Recurrent Ovarian Carcinoma Based on Elevated Tumor Marker Serum Levels

By Jimenez-Bonilla J.   Maldonado A.   Morales S.   Salud A.   Zomeno M.   Roman J.   Belon J.   Moya F.  

Clinical Positron Imaging, Vol. 3, Iss. 6, 2000-11 ,pp. : 231-236

Elsevier

Access to resources Recommend Favorite

[¹⁸F]FDG PET as a substitute for second-look laparotomy in patients with advanced ovarian carcinoma

By Kim Sungeun   Chung June-Key   Kang Soon-Beom   Kim Moon-Hong   Jeong Jae   Lee Dong   Lee Myung  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 31, Iss. 2, 2004-02 ,pp. : 196-201

Springer Publishing Company

Access to resources Recommend Favorite

Diagnostic impact of PET with ¹⁸F-FDG, ¹⁸F-DOPA and 3-O-methyl-6-[¹⁸F]fluoro-DOPA in recurrent or metastatic medullary thyroid carcinoma

By Beuthien-Baumann B.   Strumpf A.   Zessin J.   Bredow J.   Kotzerke J.  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 34, Iss. 10, 2007-10 ,pp. : 1604-1609

Springer Publishing Company

Access to resources Recommend Favorite